MILSTEIN AWARDS

Announcing the Latest Winners

The 2018 Seymour & Vivian Milstein Award for Excellence in Interferon and Cytokine Research. The ICIS recognizes two world leaders in deciphering the role of innate immunity in the host immune response.

Read More

MILSTEIN AWARDS

Announcing the Latest Winners

The 2018 Seymour & Vivian Milstein Award for Excellence in Interferon and Cytokine Research. The ICIS recognizes two world leaders in deciphering the role of innate immunity in the host immune response.

Read More

The Milstein Awards – 30 Years of Support Leading to New Treatments in Immunology, Rheumatology, Cancer, Infectious Disease and Inflammation

Prestigious.Important.Celebrated

The Seymour & Vivian Milstein Award for Excellence in Interferon and Cytokine Research, represents the pinnacle of scientific achievement in interferon and cytokine research since 1988. This award is bestowed upon a leading biomedical research scientist who has made outstanding contributions to interferon and cytokine research, either in a basic or applied field. Many laureates have made seminal advancements that have enabled the successful treatment of disease or have the potential to lead to significant health benefits.

The Milstein family–Vivian, her late husband Seymour, their son Philip and their daughter Constance–are well-known philanthropists in the United States and abroad. For more than 50 years they have provided essential support for institutions and organizations at a time when funds from government agencies have been drying up. Seymour Milstein’s early insights into the critical importance of interferons led him to Sidney Pestka, M.D., one of the scientists at the forefront of interferon research and an active member of the former ISICR, and the Milstein family’s tradition of support for organizations dedicated to patient care and scientific research, motivated him and his wife Vivian to establish The Milstein Awards in 1988, two years after interferon was first approved for the treatment of hairy cell leukemia. Read More

2018 Milstein Young Investigator Awards

No Results Found

The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.

2018 Milstein Travel Award Winners

 

Milstein Award Laureates

David Levy, Ph.D.

USA New York University Dr. Levy is a faculty member at the Sackler Institute of Graduate Biomedical Sciences at New York University School of Medicine where he is a Professor of Pathology and holds the Dr. Louis A. Schneider Endowed Chair in Molecular Pathology. He...

Sidney Pestka, M.D.

USA PBL Assay Science Dr. Pestka is known as the Father of Interferon for his seminal work on interferon that gave birth to what is, today, a $6 billion dollar market directed at the therapy of hepatitis, multiple sclerosis, cancer, and other diseases that affect...

Moshe Talpaz, M.D.

USA University of Michigan Health System Dr. Talpaz is Professor in the Department of Internal Medicine at University of Michigan Health System.  He previously served as professor in the department of experimental therapeutics at the University of Texas M.D. Anderson...

John Kirkwood, M.D.

USA University of Pittsburgh Dr. Kirkwood is Associate Director of the Division of Medical Oncology at the University of Pittsburgh Cancer Institute, where he has been the Director of the Melanoma Center since 1985. Following his relocation from Yale to the University...

Adi Kimchi, Ph.D.

ISRAEL Weizmann Institute of Science Dr. Kimchi holds the Helena Rubinstein Professorial Chair in Cancer Research at the Weizmann Institute in Israel and has headed the Department of Molecular Genetics there since January 2001.Among the prizes and honors she has...

Michael Katze, Ph.D.

USA University of Washington Dr. Katze is Professor of Microbiology at the University of Washington and Associate Director and Core Staff Scientist at the Washington National Primate Research Center. He is the Program Director for a National Institute study on Drug...

Otto Haller, Ph.D.

GERMANY Universitatsklinikum Freiburg Dr. Haller is a full pr ofessor and director of the Department of Virology at the University of Freiburg in Frieburg Germany.  His research team focuses on Mx Proteins as large GTPases involved in host defense against RNA viruses,...

George Stark, Ph.D.

USA The Cleveland Clinic Dr. George Stark graduated in Chemistry from Columbia University and became a postdoctoral fellow at the Rockefeller University. He then went to Stanford University and eventually became a Professor of Biochemistry. In 1983 he moved to the...

James E. Darnell, Jr., M.D.

USA The Rockefeller University Dr. Darnell received his M.D. in 1955 from the Washington University School of Medicine. His career has included poliovirus research with Harry Eagle at the National Institute of Allergy and Infectious Diseases, research with François...

Robert D. Schreiber, Ph.D.

USA Washington University Dr. Schreiber is the Alumni Endowed Professor of Pathology & Immunology at Washington University School of Medicine and Leader of the Tumor Immunology Program of the Washington University Siteman Cancer Center.  He received his undergraduate...

Ian Kerr, Ph.D.

UK London Research Institute Dr. I an Kerr has had a long and very distinguished career studying the mechanism of action of the interferons.  Obtaining his Ph.D. in 1963, he did postdoctoral work at Stanford and MIT, and was a group leader at the MRC National...

Paula Pitha-Rowe, Ph.D.

USA Johns Hopkins School of Medicine Dr. Pitha-Rowe has been interested in the effects viral infection on the expression of cellular genes and in the novel approaches to modulation of the antiviral and anti-inflammatory responses. She received her Ph.D. from the...

R. Michael Roberts, Ph.D.

USA University of Missouri Dr. Roberts is the Curators’ Professor of Animal Science and Biochemistry at the University of Missouri and a member of the National Academy of Sciences. He received his B.A. in botany and his Ph.D. in plant physiology and biochemistry at...

Susan Krown, M.D.

USA Memorial Sloan-Kettering Cancer Center Dr. Krown is a medical oncologist specializing in the treatment of malignant melanoma and the malignancies associated with AIDS and HIV infection. Her major clinical interests are in developing better therapies for both...

Tattanahalli L. Nagabhushan, Ph.D.

USA Schering-Plough Corporation Dr. Tattanahalli Nagabhushan was born and raised in the state of Karnataka, India.  After completing his undergraduate studies in Science at St. Philomena’s College in Mysore (B.Sc., 1953-1955), he pursued advanced studies in Chemistry...

Yukio Mitsui, Ph.D.

JAPAN Professor, Nagaoka University of Technology. Born in Tokyo, Japan, Prof. Mitsui graduated from the Department of Pharmaceutical Science of the University of Tokyo and obtained his Ph.D. in 1966. After graduation, he moved to Yale University, New Haven,...

Charles E. Bugg, Ph.D.

USA University of Alabama at Birmingham Dr. Bugg received his Ph.D. in Physical Chemistry from Rice University in 1965, and joined the faculty at University of Alabama at Birmingham after completing two years of postdoctoral study at the California Institute of...

Robert Silverman, Ph.D.

USA The Cleveland Clinic Professor Silverman is the currently the Mal and Lea Bank Chair in the Department of Cancer Biology, Lerner Research Institute at the Cleveland Clinic. He has a distinguished, nearly 40-year career studying the antiviral and anticancer...

Ian Kerr, Ph.D.

UK London Research Institute Dr. Ian Kerr has had a long and very distinguished career studying the mechanism of action of the interferons. Obtaining his Ph.D. in 1963, he did postdoctoral work at Stanford and MIT, and was a group leader at the MRC National Institute...

Hans Strander, M.D.

SWEDEN Karolinska Institutet Dr. Hans Strander, at the Department of Oncology, Radiumhemmet, Karolinska Hospital, discovered that he could give interferon to terminal bone cancer patients and double the number of long-term disease free survivors in some cases.White...

Jordan Gutterman, M.D.

USA MD Anderson Cancer Center Dr. Gutterman serves as the section head of Cellular and Molecular Growth Regulation at M.D. Anderson Cancer Center, located at the University of Texas in Houston, TX.The primary focus of his laboratory is novel plant compounds that...

Bryan R.G. Williams, Ph.D.

USA Monash Institute of Medical Research Professor Williams is currently Institute Director of the Monash Institute of Medical Research. He has a distinguished research career spanning over 30 years in the areas of innate immunity and cancer biology, and has published...

Ara G. Hovanessian, Ph.D.

FRANCE Centre National de la Recherche Scientifique Dr. Ara Giragos Hovanessian is an internationally recognized scientist who, with world authority Dr.Montagnier, identified the HIV virus at the Pasteur Institute in Paris. In his research, Dr. Ara Hovanessian...

Michel Aguet, M.D.

SWITZERLAND Ecole Polytechnique Federale de Lausanne (EPFL) Dr. Aguet received his M.D. in Zurich in 1974.He trained as a postdoctoral fellow with Dr. Ion Gresser in Villejuif, France, and moved back to the University of Zurich, where he became group leader at the...

Tadatsugu Taniguchi, Ph.D.

JAPAN University of Tokyo Dr. Taniguchi, Professor and Chair of the Immunology Laboratory, Graduate School of Medicine, University of Tokyo, has performed groundbreaking research in molecular immunology.  He was the first to isolate and characterize an interferon...

Moshe Talpaz, M.D.

USA University of Michigan Health System Dr. Talpaz is Professor in the Department of Internal Medicine at University of Michigan Health System.  He previously served as professor in the department of experimental therapeutics at the University of Texas M.D. Anderson...

John Kirkwood, M.D.

USA University of Pittsburgh Dr. Kirkwood is Associate Director of the Division of Medical Oncology at the University of Pittsburgh Cancer Institute, where he has been the Director of the Melanoma Center since 1985. Following his relocation from Yale to the University...

Adi Kimchi, Ph.D.

ISRAEL Weizmann Institute of Science Dr. Kimchi holds the Helena Rubinstein Professorial Chair in Cancer Research at the Weizmann Institute in Israel and has headed the Department of Molecular Genetics there since January 2001.Among the prizes and honors she has...

Michael Katze, Ph.D.

USA University of Washington Dr. Katze is Professor of Microbiology at the University of Washington and Associate Director and Core Staff Scientist at the Washington National Primate Research Center. He is the Program Director for a National Institute study on Drug...

Otto Haller, Ph.D.

GERMANY Universitatsklinikum Freiburg Dr. Haller is a full pr ofessor and director of the Department of Virology at the University of Freiburg in Frieburg Germany.  His research team focuses on Mx Proteins as large GTPases involved in host defense against RNA viruses,...

George Stark, Ph.D.

USA The Cleveland Clinic Dr. George Stark graduated in Chemistry from Columbia University and became a postdoctoral fellow at the Rockefeller University. He then went to Stanford University and eventually became a Professor of Biochemistry. In 1983 he moved to the...

James E. Darnell, Jr., M.D.

USA The Rockefeller University Dr. Darnell received his M.D. in 1955 from the Washington University School of Medicine. His career has included poliovirus research with Harry Eagle at the National Institute of Allergy and Infectious Diseases, research with François...

Robert D. Schreiber, Ph.D.

USA Washington University Dr. Schreiber is the Alumni Endowed Professor of Pathology & Immunology at Washington University School of Medicine and Leader of the Tumor Immunology Program of the Washington University Siteman Cancer Center.  He received his undergraduate...

Ian Kerr, Ph.D.

UK London Research Institute Dr. I an Kerr has had a long and very distinguished career studying the mechanism of action of the interferons.  Obtaining his Ph.D. in 1963, he did postdoctoral work at Stanford and MIT, and was a group leader at the MRC National...

Paula Pitha-Rowe, Ph.D.

USA Johns Hopkins School of Medicine Dr. Pitha-Rowe has been interested in the effects viral infection on the expression of cellular genes and in the novel approaches to modulation of the antiviral and anti-inflammatory responses. She received her Ph.D. from the...

R. Michael Roberts, Ph.D.

USA University of Missouri Dr. Roberts is the Curators’ Professor of Animal Science and Biochemistry at the University of Missouri and a member of the National Academy of Sciences. He received his B.A. in botany and his Ph.D. in plant physiology and biochemistry at...

Susan Krown, M.D.

USA Memorial Sloan-Kettering Cancer Center Dr. Krown is a medical oncologist specializing in the treatment of malignant melanoma and the malignancies associated with AIDS and HIV infection. Her major clinical interests are in developing better therapies for both...

Tattanahalli L. Nagabhushan, Ph.D.

USA Schering-Plough Corporation Dr. Tattanahalli Nagabhushan was born and raised in the state of Karnataka, India.  After completing his undergraduate studies in Science at St. Philomena’s College in Mysore (B.Sc., 1953-1955), he pursued advanced studies in Chemistry...

Yukio Mitsui, Ph.D.

JAPAN Professor, Nagaoka University of Technology. Born in Tokyo, Japan, Prof. Mitsui graduated from the Department of Pharmaceutical Science of the University of Tokyo and obtained his Ph.D. in 1966. After graduation, he moved to Yale University, New Haven,...

Charles E. Bugg, Ph.D.

USA University of Alabama at Birmingham Dr. Bugg received his Ph.D. in Physical Chemistry from Rice University in 1965, and joined the faculty at University of Alabama at Birmingham after completing two years of postdoctoral study at the California Institute of...

Robert Silverman, Ph.D.

USA The Cleveland Clinic Professor Silverman is the currently the Mal and Lea Bank Chair in the Department of Cancer Biology, Lerner Research Institute at the Cleveland Clinic. He has a distinguished, nearly 40-year career studying the antiviral and anticancer...

Ian Kerr, Ph.D.

UK London Research Institute Dr. Ian Kerr has had a long and very distinguished career studying the mechanism of action of the interferons. Obtaining his Ph.D. in 1963, he did postdoctoral work at Stanford and MIT, and was a group leader at the MRC National Institute...

Hans Strander, M.D.

SWEDEN Karolinska Institutet Dr. Hans Strander, at the Department of Oncology, Radiumhemmet, Karolinska Hospital, discovered that he could give interferon to terminal bone cancer patients and double the number of long-term disease free survivors in some cases.White...

Jordan Gutterman, M.D.

USA MD Anderson Cancer Center Dr. Gutterman serves as the section head of Cellular and Molecular Growth Regulation at M.D. Anderson Cancer Center, located at the University of Texas in Houston, TX.The primary focus of his laboratory is novel plant compounds that...

Bryan R.G. Williams, Ph.D.

USA Monash Institute of Medical Research Professor Williams is currently Institute Director of the Monash Institute of Medical Research. He has a distinguished research career spanning over 30 years in the areas of innate immunity and cancer biology, and has published...

Ara G. Hovanessian, Ph.D.

FRANCE Centre National de la Recherche Scientifique Dr. Ara Giragos Hovanessian is an internationally recognized scientist who, with world authority Dr.Montagnier, identified the HIV virus at the Pasteur Institute in Paris. In his research, Dr. Ara Hovanessian...

Michel Aguet, M.D.

SWITZERLAND Ecole Polytechnique Federale de Lausanne (EPFL) Dr. Aguet received his M.D. in Zurich in 1974.He trained as a postdoctoral fellow with Dr. Ion Gresser in Villejuif, France, and moved back to the University of Zurich, where he became group leader at the...

Tadatsugu Taniguchi, Ph.D.

JAPAN University of Tokyo Dr. Taniguchi, Professor and Chair of the Immunology Laboratory, Graduate School of Medicine, University of Tokyo, has performed groundbreaking research in molecular immunology.  He was the first to isolate and characterize an interferon...